Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharmacyte Biotech Inc (PMCB)

Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,006
  • Shares Outstanding, K 8,453
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,320 K
  • 60-Month Beta -0.18
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.58
Trade PMCB with:

Options Overview Details

View History
  • Implied Volatility 126.49% ( +76.50%)
  • Historical Volatility 56.32%
  • IV Percentile 74%
  • IV Rank 15.98%
  • IV High 576.09% on 04/10/24
  • IV Low 40.97% on 06/16/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 296
  • Volume Avg (30-Day) 57
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 32
  • Open Int (30-Day) 211

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.07 +6.28%
on 04/18/24
2.58 -14.73%
on 03/27/24
-0.24 (-9.84%)
since 03/22/24
3-Month
1.94 +13.40%
on 03/18/24
2.58 -14.73%
on 03/27/24
+0.01 (+0.45%)
since 01/24/24
52-Week
1.92 +14.58%
on 11/20/23
3.23 -31.89%
on 06/05/23
-0.78 (-26.17%)
since 04/24/23

Most Recent Stories

More News
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box ® for potential...

PMCB : 2.20 (+3.29%)
PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 2.20 (+3.29%)
PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 2.20 (+3.29%)
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 2.20 (+3.29%)
PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 2.20 (+3.29%)
PharmaCyte Biotech Announces Preliminary Unaudited Financial Results for Fiscal Year 2022

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 2.20 (+3.29%)
IROQUOIS CAPITAL COMMENCES CONSENT SOLICITATION TO RECONSTITUTE PHARMACYTE BIOTECH BOARD OF DIRECTORS

/PRNewswire/ -- Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), announced that on Friday, July 8, 2022, that it had delivered a...

PMCB : 2.20 (+3.29%)
IROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT ACTIONS BY THE PHARMACYTE BIOTECH BOARD OF DIRECTORS

/PRNewswire/ -- Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest stockholders of PharmaCyte Biotech, Inc....

PMCB : 2.20 (+3.29%)
PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 2.20 (+3.29%)
IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING

/PRNewswire/ -- Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest stockholders of PharmaCyte Biotech, Inc....

PMCB : 2.20 (+3.29%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Business Summary

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is...

See More

Key Turning Points

3rd Resistance Point 2.31
2nd Resistance Point 2.25
1st Resistance Point 2.23
Last Price 2.20
1st Support Level 2.15
2nd Support Level 2.09
3rd Support Level 2.07

See More

52-Week High 3.23
Fibonacci 61.8% 2.73
Fibonacci 50% 2.58
Fibonacci 38.2% 2.42
Last Price 2.20
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar